Publication:
Kidney microRNA Expression Pattern in Type 2 Diabetic Nephropathy in BTBR Ob/Ob Mice.

dc.contributor.authorOpazo-Rios, Lucas
dc.contributor.authorTejera-Muñoz, Antonio
dc.contributor.authorSoto Catalan, Manuel
dc.contributor.authorMarchant, Vanessa
dc.contributor.authorLavoz, Carolina
dc.contributor.authorMas Fontao, Sebastian
dc.contributor.authorMoreno, Juan Antonio
dc.contributor.authorFierro Fernandez, Marta
dc.contributor.authorRamos, Ricardo
dc.contributor.authorSuarez-Alvarez, Beatriz
dc.contributor.authorLopez-Larrea, Carlos
dc.contributor.authorRuiz-Ortega, Marta
dc.contributor.authorEgido, Jesus
dc.contributor.authorRodrigues-Diez, Raul R
dc.contributor.funderInstituto de Salud Carlos III (ISCIII)
dc.contributor.funderFondos FEDER European Union
dc.contributor.funderConsejería de Salud y Familias-FEDER, Junta de Andalucía
dc.contributor.funderMINECO
dc.contributor.funderSpanish Ministry of Science and Innovation
dc.date.accessioned2023-05-03T13:44:22Z
dc.date.available2023-05-03T13:44:22Z
dc.date.issued2022-02-10
dc.description.abstractDiabetic nephropathy (DN) is the main leading cause of chronic kidney disease worldwide. Although remarkable therapeutic advances have been made during the last few years, there still exists a high residual risk of disease progression to end-stage renal failure. To further understand the pathogenesis of tissue injury in this disease, by means of the Next-Generation Sequencing, we have studied the microRNA (miRNA) differential expression pattern in kidneys of Black and Tan Brachyury (BTBR) ob/ob (leptin deficiency mutation) mouse. This experimental model of type 2 diabetes and obesity recapitulates the key histopathological features described in advanced human DN and therefore can provide potential useful translational information. The miRNA-seq analysis, performed in the renal cortex of 22-week-old BTBR ob/ob mice, pointed out a set of 99 miRNAs significantly increased compared to non-diabetic, non-obese control mice of the same age, whereas no miRNAs were significantly decreased. Among them, miR-802, miR-34a, miR-132, miR-101a, and mir-379 were the most upregulated ones in diabetic kidneys. The in silico prediction of potential targets for the 99 miRNAs highlighted inflammatory and immune processes, as the most relevant pathways, emphasizing the importance of inflammation in the pathogenesis of kidney damage associated to diabetes. Other identified top canonical pathways were adipogenesis (related with ectopic fatty accumulation), necroptosis (an inflammatory and regulated form of cell death), and epithelial-to-mesenchymal transition, the latter supporting the importance of tubular cell phenotype changes in the pathogenesis of DN. These findings could facilitate a better understanding of this complex disease and potentially open new avenues for the design of novel therapeutic approaches to DN.
dc.description.versionSi
dc.identifier.citationOpazo-Ríos L, Tejera-Muñoz A, Soto Catalan M, Marchant V, Lavoz C, Mas Fontao S, et al. Kidney microRNA Expression Pattern in Type 2 Diabetic Nephropathy in BTBR Ob/Ob Mice. Front Pharmacol. 2022 Mar 16;13:778776
dc.identifier.doi10.3389/fphar.2022.778776
dc.identifier.issn1663-9812
dc.identifier.pmcPMC8966705
dc.identifier.pmid35370692
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966705/pdf
dc.identifier.unpaywallURLhttps://www.frontiersin.org/articles/10.3389/fphar.2022.778776/pdf
dc.identifier.urihttp://hdl.handle.net/10668/20701
dc.journal.titleFrontiers in pharmacology
dc.journal.titleabbreviationFront Pharmacol
dc.language.isoen
dc.organizationHospital Universitario Reina Sofía
dc.organizationInstituto Maimónides de Investigación Biomédica de Córdoba-IMIBIC
dc.page.number17
dc.publisherFrontiers Research Foundation
dc.pubmedtypeJournal Article
dc.relation.projectIDPI17/01495
dc.relation.projectIDEIN 2019-103294
dc.relation.projectIDRYC-2017-22369
dc.relation.projectIDPI20/00487
dc.relation.projectIDPI20/00375
dc.relation.publisherversionhttps://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.778776/full
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectBTBR ob/ob mice
dc.subjectChronic kidney disease
dc.subjectDiabetes
dc.subjectDiabetic nephropaty
dc.subjectInflammation
dc.subjectMiRNA
dc.subjectType 2 diabetes
dc.subject.decsDiabetes mellitus tipo 2
dc.subject.decsFallo renal crónico
dc.subject.decsInmunidad
dc.subject.decsInsuficiencia renal crónica
dc.subject.decsLeptina
dc.subject.decsNefropatías diabéticas
dc.subject.meshDiabetic nephropathies
dc.subject.meshLeptin
dc.subject.meshBrachyury protein
dc.subject.meshDiabetes mellitus, type 2
dc.subject.meshKidney failure, chronic
dc.subject.meshRenal insufficiency, chronic
dc.subject.meshImmunity
dc.titleKidney microRNA Expression Pattern in Type 2 Diabetic Nephropathy in BTBR Ob/Ob Mice.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number13
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
PMC8966705.pdf
Size:
2.48 MB
Format:
Adobe Portable Document Format
No Thumbnail Available
Name:
Opazo-Rios_KidneyMicroRNA_MaterialSuplementario.zip
Size:
40.91 KB
Format: